With scientific and technological advancements, the pharmaceutical industry is no longer just for the big companies. Changes in risk profiles and assets no longer just being physical, clients need to know that they are covered for the new world. TMK's underwriting approach to intellectual property, non-damage business interruption and trade credit will support pharmaceutical companies in their drive to grow and develop new medicines.